Details for Patent: 8,722,657
✉ Email this page to a colleague
Which drugs does patent 8,722,657 protect, and when does it expire?
Patent 8,722,657 protects VENCLEXTA and is included in one NDA.
This patent has thirty-two patent family members in twenty-six countries.
Summary for Patent: 8,722,657
Title: | Salts and crystalline forms of an apoptosis-inducing agent |
Abstract: | Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin- -1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}-sulfon- yl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide are suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer. |
Inventor(s): | Catron; Nathaniel (Vernon Hills, IL), Chen; Shuang (Gurnee, IL), Gong; Yuchuan (Waukegan, IL), Zhang; Geoff G. (Vernon Hills, IL) |
Assignee: | Abbvie Inc. (North Chicago, IL) |
Application Number: | 13/301,257 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,722,657 |
Patent Claim Types: see list of patent claims | Composition; Compound; Process; |
Drugs Protected by US Patent 8,722,657
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | VENCLEXTA | venetoclax | TABLET;ORAL | 208573-001 | Apr 11, 2016 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Abbvie | VENCLEXTA | venetoclax | TABLET;ORAL | 208573-002 | Apr 11, 2016 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Abbvie | VENCLEXTA | venetoclax | TABLET;ORAL | 208573-003 | Apr 11, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,722,657
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2011332043 | ⤷ Try a Trial | |||
Brazil | 112013012740 | ⤷ Try a Trial | |||
Canada | 2817629 | ⤷ Try a Trial | |||
China | 103328474 | ⤷ Try a Trial | |||
China | 107266435 | ⤷ Try a Trial | |||
Cyprus | 1119648 | ⤷ Try a Trial | |||
Denmark | 2643322 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |